A detailed history of Raab & Moskowitz Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 907 shares of AMGN stock, worth $267,138. This represents 0.07% of its overall portfolio holdings.

Number of Shares
907
Previous 924 1.84%
Holding current value
$267,138
Previous $288,000 1.39%
% of portfolio
0.07%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$309.38 - $337.38 $5,259 - $5,735
-17 Reduced 1.84%
907 $292,000
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $26,537 - $32,250
101 Added 12.27%
924 $288,000
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $13,443 - $16,228
50 Added 6.47%
823 $233,000
Q4 2023

Feb 02, 2024

SELL
$255.7 - $288.46 $34,775 - $39,230
-136 Reduced 14.96%
773 $222,000
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $198,752 - $246,757
909 New
909 $244,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $5,644 - $6,880
-25 Reduced 2.83%
858 $207,000
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $202,233 - $256,961
883 New
883 $0
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $4,614 - $5,134
20 Added 2.25%
908 $220,000
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $176,605 - $202,108
888 New
888 $200,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $198,047 - $232,037
-933 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $4,327 - $5,153
20 Added 2.19%
933 $214,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $18,772 - $20,876
-80 Reduced 8.06%
913 $232,000
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $395 - $485
2 Added 0.2%
993 $234,000
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $1,275 - $1,691
-7 Reduced 0.7%
991 $200,000
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $188,831 - $242,713
998 New
998 $240,000
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $196,047 - $234,906
-1,126 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $187,704 - $220,031
1,126 New
1,126 $207,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $231,694 - $261,170
-1,281 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$178.4 - $208.25 $140,400 - $163,892
787 Added 159.31%
1,281 $249,000
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $91,533 - $103,191
494 New
494 $102,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Raab & Moskowitz Asset Management LLC Portfolio

Follow Raab & Moskowitz Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.